版本:
中国

BRIEF-Seres Therapeutics reports Q4 and full year 2016 financial results

March 16 Seres Therapeutics Inc -

* Seres Therapeutics reports fourth quarter and full year 2016 financial results and provides operational progress update

* Q4 revenue $3.0 million versus I/B/E/S view $2.9 million

* Ended q4 with approximately $230.0 million in cash, cash equivalents and investments

* Expects its existing cash resources will enable it to fund operating expenses and capital expenditure requirements through 2018 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐